Inventor
CANSFIELD JULIE ELAINE
GB24 patents
⚠️ This page may combine multiple inventors who share the name “CANSFIELD JULIE ELAINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEPTARES THERAPEUTICS LTD
23 patentsUS9670183B2Jun 6, 2017
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD34 citations98
US10961225B2Mar 30, 2021
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD11 citations94
US10689368B2Jun 23, 2020
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD12 citations94
US10196380B2Feb 5, 2019
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD20 citations94
US9926297B2Mar 27, 2018
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
HEPTARES THERAPEUTICS LTD19 citations94
US10030035B2Jul 24, 2018
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD14 citations93
US9907805B2Mar 6, 2018
Muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD15 citations93
US9669013B2Jun 6, 2017
Bicyclic aza compounds as muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD14 citations93
US9573929B2Feb 21, 2017
Muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD12 citations93
US9266857B2Feb 23, 2016
Bicyclic AZA compounds as muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD23 citations93
US10385039B2Aug 20, 2019
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
HEPTARES THERAPEUTICS LTD13 citations92
US11352342B2Jun 7, 2022
Pharmaceutical compounds
HEPTARES THERAPEUTICS LTD9 citations86
US11254656B2Feb 22, 2022
Muscarinic agonists
HEPTARES THERAPEUTICS LTD10 citations86
US11034704B2Jun 15, 2021
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD10 citations86
US10973832B2Apr 13, 2021
Muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD10 citations86
US10752610B2Aug 25, 2020
Pharmaceutical compounds
HEPTARES THERAPEUTICS LTD10 citations84
US10428088B2Oct 1, 2019
Muscarinic receptor agonists
HEPTARES THERAPEUTICS LTD11 citations84
US10413553B2Sep 17, 2019
Muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD11 citations84
US10329278B2Jun 25, 2019
Pharmaceutical compounds
HEPTARES THERAPEUTICS LTD13 citations84
US10259802B2Apr 16, 2019
Bicyclic aza compounds as muscarinic M1 receptor antagonists
HEPTARES THERAPEUTICS LTD9 citations84
US10167284B2Jan 1, 2019
Spirocyclic compounds as agonists of the muscarinic M1 receptor and/or M4 receptor
HEPTARES THERAPEUTICS LTD12 citations84
US9975890B2May 22, 2018
Bicyclic AZA compounds as muscarinic M1 receptor antagonists
HEPTARES THERAPEUTICS LTD10 citations84
US11793817B2Oct 24, 2023
Muscarinic M1 receptor agonists
HEPTARES THERAPEUTICS LTD0 citations63